PHILADELPHIA--(BUSINESS WIRE)--To support the creation of Ebola virus vaccines and treatments, Integral Molecular, a leader in membrane protein antibody discovery, has identified the key molecular interactions that mediate the effectiveness of the anti-Ebola ZMappTM therapeutic cocktail, which is in clinical trials after being used to treat select patients during the 2014 Ebola virus outbreak.
Help employers find you! Check out all the jobs and post your resume.
